{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "G",
          "alt": "D",
          "position": "309"
        },
        "variant_string_id": "PINK1 G309D"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper states that PINK1 mutations lead to neurodegeneration via impaired TRAP1 phosphorylation, which disrupts mitochondrial protection against oxidative stress.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly links PINK1 dysfunction to mitochondrial apoptosis via TRAP1 phosphorylation, defining a clear disease mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses phosphorylation assays (TRAP1 phosphorylation) and cell survival assays (cytochrome c release) to model mitochondrial dysfunction.",
          "judgment": "Yes",
          "reasoning": "Phosphorylation and cell survival assays directly reflect mitochondrial function and apoptosis, aligning with the defined mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper reports that PD-linked mutations (G309D, L347P, W437X) impair PINK1's ability to phosphorylate TRAP1 and promote cell survival but does not explicitly mention controls or replicates.",
          "judgment": "No",
          "reasoning": "No explicit mention of positive/negative controls or replicates in the abstract/methods section.",
          "next_step_or_outcome": "Proceed to Step 3b"
        },
        {
          "step_name": "Step 3b: Assess standardization of assays",
          "extracted_paper_info": "Phosphorylation assays and cell death models are standard in mitochondrial research, though the paper does not cite prior validation.",
          "judgment": "Yes",
          "reasoning": "Assays are foundational in mitochondrial biology, implying standardization despite lack of explicit citation.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The study demonstrates functional impairment of all three mutations but does not report statistical metrics (p-values, OddsPath) or control variant counts.",
          "judgment": "No",
          "reasoning": "No statistical analysis or control variant counts are provided to quantify pathogenicity.",
          "next_step_or_outcome": "Proceed to Step 4b"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study uses three PD-linked variants but does not specify total benign/pathogenic controls used in the assay.",
          "judgment": "No",
          "reasoning": "Insufficient data on control variant numbers to apply quantitative thresholds.",
          "next_step_or_outcome": "Assign Max PS3_supporting"
        }
      ],
      "evidence_strength": "PS3_supporting"
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "L",
          "alt": "P",
          "position": "347"
        },
        "variant_string_id": "PINK1 L347P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper states that PINK1 mutations lead to neurodegeneration via impaired TRAP1 phosphorylation, which disrupts mitochondrial protection against oxidative stress.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly links PINK1 dysfunction to mitochondrial apoptosis via TRAP1 phosphorylation, defining a clear disease mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses phosphorylation assays (TRAP1 phosphorylation) and cell survival assays (cytochrome c release) to model mitochondrial dysfunction.",
          "judgment": "Yes",
          "reasoning": "Phosphorylation and cell survival assays directly reflect mitochondrial function and apoptosis, aligning with the defined mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper reports that PD-linked mutations (G309D, L347P, W437X) impair PINK1's ability to phosphorylate TRAP1 and promote cell survival but does not explicitly mention controls or replicates.",
          "judgment": "No",
          "reasoning": "No explicit mention of positive/negative controls or replicates in the abstract/methods section.",
          "next_step_or_outcome": "Proceed to Step 3b"
        },
        {
          "step_name": "Step 3b: Assess standardization of assays",
          "extracted_paper_info": "Phosphorylation assays and cell death models are standard in mitochondrial research, though the paper does not cite prior validation.",
          "judgment": "Yes",
          "reasoning": "Assays are foundational in mitochondrial biology, implying standardization despite lack of explicit citation.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The study demonstrates functional impairment of all three mutations but does not report statistical metrics (p-values, OddsPath) or control variant counts.",
          "judgment": "No",
          "reasoning": "No statistical analysis or control variant counts are provided to quantify pathogenicity.",
          "next_step_or_outcome": "Proceed to Step 4b"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study uses three PD-linked variants but does not specify total benign/pathogenic controls used in the assay.",
          "judgment": "No",
          "reasoning": "Insufficient data on control variant numbers to apply quantitative thresholds.",
          "next_step_or_outcome": "Assign Max PS3_supporting"
        }
      ],
      "evidence_strength": "PS3_supporting"
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "W",
          "alt": "X",
          "position": "437"
        },
        "variant_string_id": "PINK1 W437X"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper states that PINK1 mutations lead to neurodegeneration via impaired TRAP1 phosphorylation, which disrupts mitochondrial protection against oxidative stress.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly links PINK1 dysfunction to mitochondrial apoptosis via TRAP1 phosphorylation, defining a clear disease mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses phosphorylation assays (TRAP1 phosphorylation) and cell survival assays (cytochrome c release) to model mitochondrial dysfunction.",
          "judgment": "Yes",
          "reasoning": "Phosphorylation and cell survival assays directly reflect mitochondrial function and apoptosis, aligning with the defined mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper reports that PD-linked mutations (G309D, L347P, W437X) impair PINK1's ability to phosphorylate TRAP1 and promote cell survival but does not explicitly mention controls or replicates.",
          "judgment": "No",
          "reasoning": "No explicit mention of positive/negative controls or replicates in the abstract/methods section.",
          "next_step_or_outcome": "Proceed to Step 3b"
        },
        {
          "step_name": "Step 3b: Assess standardization of assays",
          "extracted_paper_info": "Phosphorylation assays and cell death models are standard in mitochondrial research, though the paper does not cite prior validation.",
          "judgment": "Yes",
          "reasoning": "Assays are foundational in mitochondrial biology, implying standardization despite lack of explicit citation.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The study demonstrates functional impairment of all three mutations but does not report statistical metrics (p-values, OddsPath) or control variant counts.",
          "judgment": "No",
          "reasoning": "No statistical analysis or control variant counts are provided to quantify pathogenicity.",
          "next_step_or_outcome": "Proceed to Step 4b"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study uses three PD-linked variants but does not specify total benign/pathogenic controls used in the assay.",
          "judgment": "No",
          "reasoning": "Insufficient data on control variant numbers to apply quantitative thresholds.",
          "next_step_or_outcome": "Assign Max PS3_supporting"
        }
      ],
      "evidence_strength": "PS3_supporting"
    }
  ]
}